Pharmacy Law Home Study for Pharmacists and Pharmacy Technicians Preparing Your Pharmacy for a DEA Inspection

Similar documents
Pharmacy Law Home Study for Pharmacists and Pharmacy Technicians Preparing Your Pharmacy for a DEA Inspection

Pharmacy Law Home Study for Pharmacists and Pharmacy Technicians Medication Errors: Mitigating Occurrences & Minimizing Risk with New Technologies

2015 Annual Convention

Patient Safety Professional Program: Pre-work

Nebraska Pharmacy Law 2015

Chapter 1: Overview of Texas Pharmacy Law 1 Contact Hour (Mandatory)

Idaho Pharmacy Law: Developments and Practical Applications

A Systematic Approach to Consultant Pharmacy Services

Estimated time to complete activity: 1.5 hours for medical professionals, 3 hours for non medical professionals

PRS 101 FOUNDATIONS OF PHARMACY REGULATION PRS INTRO TO PHARMACY REGULATION:

A PRIMER ON MEDICATION SYNCHRONIZATION JULY 14, :45 8:45 AM

ACPE Standards for Continuing Pharmacy Education. Standard 1: Mission and Goals of CPE. Standard 1: Goal and Mission of the.

TECHNICIAN LAW REVIEW. Objectives. Outline 9/20/2012

Pharmacy Law Update for Pharmacists & Technicians October 1, 2017 Greg Baran, B.S., Pharm., M.A.

Idaho Pharmacy Law: Update and Practical Applications

Jointly provided by Postgraduate Institute for Medicine and U.S. Department of Health and Human Services

10/4/12. Controlled Substances Dispensing Issues and Solutions. Objectives. Financial Disclosure

Frequently Asked Questions

Regulatory Agencies Impact on Health System Pharmacies

Validation of Education Activity Content. All departments developing and presenting continuing education programs certified for credit by LVHN.

Medication Errors: Mitigating Occurrences & Minimizing Risk with New Technologies

CE/CME Evaluation & Credit Claim Form TITLE OF ACTIVITY: Prescribing Practices of Controlled Substance

A Systematic Approach to Consultant Pharmacy Services

Secretary of State Office of Professional Regulation BOARD OF PHARMACY 89 Main Street, 3 rd Floor Montpelier, VT

What s New? Objectives. Disclosures. PTCB Certified Pharmacy Technicians: Playing a Critical Role in Practice Model Change

AMENDMENT TO SENATE BILL 772. AMENDMENT NO.. Amend Senate Bill 772, AS AMENDED, by. replacing everything after the enacting clause with the following:

Delivering Medication Therapy Management Services in the Community hosted by St. John s University College of Pharmacy and Health Sciences

McConnell AFB Pharmacy Frequently Asked Questions

Inaugural Three Rivers Antimicrobial Stewardship Symposium

Prescription Drug Monitoring Program (PDMP)

Georgia DPH. Prescription Title Drug Heading Monitoring Program Program. Sheila Pierce April 2018

IC Chapter 19. Regulation of Pharmacy Technicians

The Wisconsin epdmp:

TeamSTEPPS Course Coordinator Requirements and Processes for Continuing Education (CE) Credit and the Online Registration Center (ORC) August 2016

DC Board of Pharmacy and Pharmaceutical Control Update

Accreditation Crosswalk

Missouri Board Of Pharmacy

TEXAS PHARMACY LAW AND RULES UPDATE FOR COMMUNITY PHARMACIES JULIE STRICKLAND, PHARMD

Eligibility Organizations are eligible to seek accreditation as a provider of continuing education for the healthcare

Hydrocodone Prescribing and the New Texas PMP

Delegator Dashboard User Guide

CONTINUING PHARMACY EDUCATION (CPE) Project Planning Form for Live and Enduring Activities

ALABAMA BOARD OF NURSING ADMINISTRATIVE CODE CHAPTER 610-X-10 CONTINUING EDUCATION FOR LICENSURE TABLE OF CONTENTS

The Increasing Role of ND Pharmacy Technicians in Prescription Counseling. Tyler Rogers, PharmD, RPh

Joseph J. Bova, RPh. This program has been brought to you by PharmCon

Thank you for coming to our San Antonio Workshop THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER

Measuring Impact in Patient-Centered Drug Development Conference

(7) Indicate the appropriate and explicit directions for use. (9) Not authorize any refills for schedule II controlled substances.

District of Columbia Prescription Drug Monitoring Program

EPCS FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES. Revised: March 2016

NATIONAL ASSOCIATION FOR STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT (2016) COMMENT

October 29, 2009 Board of Pharmacy Office Bismarck, ND A G E N D A - CONFERENCE CALL MEETING 10:00 AM - THURSDAY OCTOBER 29 TH, 2009

Payment: We are permitted to use and disclose your health information to receive payment for our services. For example, we may:

APPROVED REGULATION OF THE STATE BOARD OF PHARMACY. LCB File No. R Effective May 16, 2018

Application for Massachusetts Controlled Substances Registration for Advanced Practice Registered Nurses and Physician Assistants

MEMO. DATE June Licensed Speech-Language Pathologist and Audiologist, Applicants for licenses and other interested persons

AADE CORPORATE SYMPOSIA

Disclosures. Exploration of Telepharmacy: History of Telepharmacy 8/14/2014. Pharmacist and Technician Objectives

How to Get the Most Out of Prescription Drug Monitoring Programs

Statement of Ronna B. Hauser, Pharm.D. Vice President, Policy and Regulatory Affairs National Community Pharmacists Association

Post-Test/ Evaluation

Culturally Responsive. Friday. Health Care in Iowa THE UNIVERSITY OF IOWA PRESENTS

Culturally Responsive. Friday. Health Care in Iowa THE UNIVERSITY OF IOWA PRESENTS

MARYLAND BOARD OF PHYSICIANS P.O. Box 2571 Baltimore, Maryland

NEW JERSEY REGULATORY UPDATE November-December 2004

NCPDP s Recommendations for an Integrated, Interoperable Solution to Ensure Patient Safe Use of Controlled Substances

Prescription Monitoring Program:

Disclosures. Learning Objectives. Pharmacy Law Topics. Spring Seminar 2017

Advancing MN Pharmacy 2016 Advocacy Accomplishments & 2017 Plans

INSTRUCTIONS FOR SUBMISSION OF AUDIT DOCUMENTATION CHECKLIST AUDIT MATERIALS FOR INITIAL CERTIFICATION

A FREE Certificate Training Program for Pharmacists

RULES and REGULATIONS: PRESCRIBING CONTROLLED SUBSTANCES IN MS. Mississippi State Board of Medical Licensure June 24, 2016 Thomas Washington, CMBI

PHARMACY JURISPRUDENCE, L.L.C. Volume 8, Issue 2 Expires: February 5, 2010

Prescription Drug Monitoring Program (PDMP)

Regulation of Hospital Pharmacy. Board of Pharmacy Authority. The New & Proposed Changes to the Hospital Licensing Rules. Conflict of Interests

Ohio. Contact Information. State Registrant Totals and Population

Effective Date: 11/09 Policy Chronicle:

Understanding Diversion in the Pharmacy Kimberly S. New JD BSN RN

Drug and Medical Device Registration FAQ

Prescription Monitoring Program State Profiles - Illinois

California Pharmacy Law Update 2018

Definitions: In this chapter, unless the context or subject matter otherwise requires:

Controlled Management

DC Board of Pharmacy and Pharmaceutical Control Update

INSTRUCTIONS FOR SUBMISSION OF AUDIT DOCUMENTATION CHECKLIST AUDIT MATERIALS FOR INITIAL CERTIFICATION

Medication Safety LAN Event A Review of Patient Activation and Prescription Drug Monitoring Resources to Enhance Medication Management with Patients.

Other Health Care Providers (Part II) Holly L. Mason, R.Ph., Ph.D. PHRM 831

Session 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER

THE CONFERENCE WHERE MEDICAL HOME NEIGHBORS TRANSFORM CARE DELIVERY

Friday: April 4, 2014 Rutgers University Inn and Conference Center 178 Ryders Lane, New Brunswick, NJ

Maryland. Prescribing and Dispensing Profile. Research current through November 2015.

Michael D. Bullek BSP R.Ph. Administrator/Chief of Compliance New Hampshire Board of Pharmacy

Please adjust your computer volume to a comfortable listening level. This is lesson 4 How do you handle medication at home?

Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center

NEW JERSEY. Downloaded January 2011

SUBCHAPTER 32M - APPROVAL OF NURSE PRACTITIONERS

Delivering Medication Therapy Management Services A Certificate Training Program for Pharmacists

CONSULTANT PHARMACIST INSPECTION LAW REVIEW

ROUND LAKE Journey Toward Healthy. Treatment Centre

Prescription Monitoring Program State Profiles - Michigan

Transcription:

Pharmacy Law Home Study for Pharmacists and Pharmacy Technicians (Knowledge-Based CPE Activity) No sponsorship was received for this law program Program Goal and Objectives The purpose of this home study activity is to provide comprehensive education for pharmacists and pharmacy technicians on the topic of the Drug Enforcement Administration, diversion, and their audits regarding controlled dangerous substances (CDS). The audience will learn the issues facing pharmacists and the top audit areas. The at-risk areas for CDS is discussed and proper protocol is addressed in detail. The participant will know the schedule II substances dispensing requirements and the NJ opioid law. As the pharmacist, they are responsible to ensure the CDS are for a valid medical purpose. Emergency dispensing and partial filling of CDS prescriptions is explained. Also, in this activity, electronic, invalid, and illegitimate prescription procedures are described. The pharmacist will also learn of the updated regulations starting with their 2019 biennial license renewal to complete one (1) credit of CE program on the topic of opioid drugs. At the completion of this program, the pharmacist participant will be able to: discuss the common elements of a DEA audit; explain the legal ramifications of a DEA audit, including potential civil, criminal, and administrative penalties; discuss the legal rights and responsibilities of the pharmacy undergoing a DEA audit; and identify good practices that will help simplify the audit process. At the completion of this program, the pharmacy technician participant will be able to: recognize the breadth and scope of the drug diversion problem; describe common types of drug diversion schemes; define good practices that will help secure control substances; and explain statutory record keeping requirements. Continuing Education Credit Release Date: 08/02/2017 Expiration Date: 08/02/2018 No credit will be give after the expiration date Fee: The fee for this educational activity is $20 Program Audience: Registered Pharmacists and Pharmacy Technicians 1

In support of improving patient care, Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. This program is approved for 0.10 CEU (1.00 contact hour) law continuing education credit. In order to receive 1.00 law contact hour of CE credit, the participant must read the slides, complete the post-test questions with at least a score of 70% and complete the on-line evaluation. If participant fails first time, may retake the post-test questions at an additional fee of $20. Continuing education credits (paperless) can be viewed at www.mycpemonitor.net two weeks after passing the post-test questions. The Universal Activity Number is 0374-0000-17-031-H03-P-T. Effective 07-01-2018 the Universal Activity Number is JA0000855-0000-18-011- H03-P-T. (Knowledge-Based CPE Activity) Course Development Angelo Cifaldi, R.Ph., J.D. acifaldi@wilentz.com Adjunct Associate Professor or Pharmacy Law, Rutgers University, Ernest Mario School of Pharmacy Wilentz, Goldman and Spitzer Attorneys at Law Satish V. Poondi, R.Ph., Esq. spoondi@wilentz.com 732-855-6154 Wilentz, Goldman, & Spitzer P.A 90 Woodbridge Center Drive Woodbridge, NJ 07095 Reviewer Mary Bridgeman, PharmD, BCPS, CGP Clinical Assistant Professor Rutgers University, Ernest Mario School of Pharmacy Internal Medicine/Nephrology Robert Wood Johnson University Hospital Contact Person Please contact Gerry Murphy, Program Coordinator, should problems related to the content or functioning of the continuing education activity arise: Email: Telephone: Mail: gemurphy@pharmacy.rutgers.edu 848-445-6823 (8:00 am - 4:00 pm - Monday thru Friday) Rutgers, The State University of New Jersey Ernest Mario School of Pharmacy Attn: Gerry Murphy Room 258 160 Frelinghuysen Road Piscataway, NJ 08854-8020 2

Post-Test Questions (Circle your answers on the Post-Test Answer Form on page 4) (Mailing instructions are also on page 4) (Knowledge-Based CPE Activity) 1. A pharmacist receives a prescription for Oxycodone 30 mg tablets. It is written for a five-day supply and the prescription states it is an initial prescription. On reviewing the prescription, the pharmacist notices that the patient s address is missing. Which of the following is true? A. The pharmacist may not fill the prescription since the address is incomplete B. The patient s address is not needed to fill the prescription C. The patient s address may be added without consultation with the prescriber D. The pharmacist may add the patient s address only after consultation with the prescriber 2. In addition to NJ, the NJ PMP can provide information relating to prescription filled in how many other states? A. None B. 2 C. 5 D. 7 3. A loss of controlled substance is considered significant if A. Only if more than 5,000 units were lost B. A potential thief has been identified C. Only if the medication lost is a schedule II substance D. None of the above 4. A voluntary surrender of a DEA registration by a practitioner is effective A. Immediately B. One week from the signature C. In 72 hours D. In 48 hours 5. Which of the following is true about the inventory records maintained by a pharmacy? A. The inventory needs to note the date that it is taken, but not the time B. It is sufficient to keep an oral recording of the inventory (e.g. on audio tape) C. The pharmacy must maintain an exact count of all CIIs D. None of the above THE END 3

Pharmacy Program Post-Test Answer Form (Circle answers and mail this page with Name Form on pg. 5) **IMPORTANT: Be sure to complete the mandatory on-line evaluation as required to receive ACPE credits. Instructions are on page 6.** Pharmacy Law Home Study (Knowledge-based CPE activity) This form and the on-line Evaluation must be completed to receive law continuing education credit. Circle your answers to the questions at the right. You can either email the Name Form and the Post-Test Answer Form (after completing the on-line Evaluation to): gemurphy@pharmacy.rutgers.edu or fax to: 732-445-5767 with credit card info fee $20 or Mail the Name Form and the Post-Test Answer Form (after completing the on-line Evaluation) along with your $20 check made payable to: Rutgers, The State University of New Jersey Circle Your Answer 1. A B C D 2. A B C D 3 A B C D 4. A B C D 5. A B C D Mail to: Rutgers, The State University of New Jersey Ernest Mario School of Pharmacy Attn: Gerry Murphy Room 258 160 Frelinghuysen Road Piscataway, NJ 08854-8020 In support of improving patient care, Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. This program is approved for 0.10 CEU (1.0 contact hour) law continuing education credit. In order to receive 1 law contact hour of CE credit, the participant must read the slides, complete the post-test questions with at least a score of 70% and complete the on-line evaluation. If participant fails first time, may retake the post-test questions at an additional fee of $20. Continuing education credits (paperless) can be viewed at www.mycpemonitor.net two weeks after passing the post-test questions. The Universal Activity Number (UAN) is 0374-0000-17-031-H03-P-T. Effective 07-01-2018 the UAN number is JA0000855-0000-18-011-H03-P-T. Initial Release Date: 08/01/2017 Expiration Date: 08/01/2018 4

Pharmacy Law Home Study (Knowledge-based CPE activity) NAME FORM Name (Print only) Check one, if applicable: R.Ph. Pharm.D. Other (specify) YOU MUST Provide: NABP e-profile # Date of Birth: (to acquire a NABP #... please go to: http://www.nabp.net) Home Address City State Zip Code Telephone (work) (home) Email Credit Card Information Name of Credit Card: Credit Card #: Expiration Date: 3 or 4 digit code on back of card: OR If paying by check: Check Number: 5

Pharmacy Law Home Study (Knowledge-based CPE activity) PROGRAM EVALUATION **The mandatory program evaluation is now located online. The direct link is: https://rutgers.ca1.qualtrics.com/jfe/form/sv_a3nymrmdt9wwbvt IMPORTANT: This electronic evaluation must be completed before submitting your name and post-test answer forms (pgs. 4 & 5). Completion is MANDATORY before CE credits can be issued to ACPE on your behalf. Thank you for your interest in Rutgers, The State University of New Jersey, Ernest Mario School of Pharmacy 6